Peroxisomal Bifunctional Enzyme Deficiency
Peroxisomal Bifunctional Enzyme Deficiency (PBED) is a rare genetic disorder that affects the peroxisomes, which are small organelles within cells responsible for various critical biochemical pathways, including the breakdown of very long-chain fatty acids (VLCFAs). This condition is part of a larger group of disorders known as Peroxisomal Biogenesis Disorders (PBDs), which also includes Zellweger Syndrome Spectrum (ZSS) and Rhizomelic Chondrodysplasia Punctata (RCDP).
Causes[edit | edit source]
PBED is caused by mutations in the HSD17B4 gene, which encodes the enzyme D-bifunctional protein (DBP). This enzyme is crucial for the proper metabolism of VLCFAs, and its deficiency leads to their accumulation in various tissues of the body, causing damage and dysfunction.
Symptoms[edit | edit source]
The symptoms of PBED can vary widely among affected individuals but generally include developmental delay, hypotonia (decreased muscle tone), seizures, hepatomegaly (enlarged liver), and abnormalities in facial features. The severity of the symptoms can range from mild to life-threatening, and they typically begin in infancy.
Diagnosis[edit | edit source]
Diagnosis of PBED involves a combination of clinical evaluation, biochemical tests (such as the analysis of VLCFA levels in blood), and genetic testing to identify mutations in the HSD17B4 gene.
Treatment[edit | edit source]
There is currently no cure for PBED, and treatment focuses on managing symptoms and preventing complications. This may include nutritional support, medications to control seizures, and physical therapy to improve muscle tone and mobility. In some cases, liver transplantation may be considered for individuals with severe liver dysfunction.
Prognosis[edit | edit source]
The prognosis for individuals with PBED varies depending on the severity of symptoms and the effectiveness of management strategies. Early diagnosis and intervention can improve the quality of life for some affected individuals, but the disorder can be life-threatening in severe cases.
| Peroxisomal Bifunctional Enzyme Deficiency Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
